Overview
Medicxi is a European investment firm focused on the life sciences sector, established in 2016 by the former Index Ventures life sciences team. The firm invests across the full drug development continuum, from discovery stage to pivotal studies and registration, with a mission to bring novel therapies to patients in need.
This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.